ID   GFPT2_HUMAN             Reviewed;         682 AA.
AC   O94808; Q53XM2; Q9BWS4;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   12-APR-2017, entry version 150.
DE   RecName: Full=Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2;
DE            EC=2.6.1.16 {ECO:0000250|UniProtKB:P82808};
DE   AltName: Full=D-fructose-6-phosphate amidotransferase 2;
DE   AltName: Full=Glutamine:fructose-6-phosphate amidotransferase 2;
DE            Short=GFAT 2;
DE            Short=GFAT2;
DE   AltName: Full=Hexosephosphate aminotransferase 2;
GN   Name=GFPT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Thymus;
RX   PubMed=10198162; DOI=10.1006/geno.1999.5785;
RA   Oki T., Yamazaki K., Kuromitsu J., Okada M., Tanaka I.;
RT   "cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-
RT   phosphate amidotransferase (GFAT2) in human and mouse.";
RL   Genomics 57:227-234(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-471.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Controls the flux of glucose into the hexosamine
CC       pathway. Most likely involved in regulating the availability of
CC       precursors for N- and O-linked glycosylation of proteins.
CC   -!- CATALYTIC ACTIVITY: L-glutamine + D-fructose 6-phosphate = L-
CC       glutamate + D-glucosamine 6-phosphate.
CC       {ECO:0000250|UniProtKB:P82808}.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; alpha-D-glucosamine 6-phosphate from D-
CC       fructose 6-phosphate: step 1/1. {ECO:0000250|UniProtKB:P82808}.
CC   -!- INTERACTION:
CC       Q9NUX5:POT1; NbExp=2; IntAct=EBI-6916534, EBI-752420;
CC   -!- TISSUE SPECIFICITY: Highest levels of expression in heart,
CC       placenta, and spinal cord.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB016789; BAA74731.1; -; mRNA.
DR   EMBL; BT009818; AAP88820.1; -; mRNA.
DR   EMBL; BC000012; AAH00012.1; -; mRNA.
DR   CCDS; CCDS43411.1; -.
DR   RefSeq; NP_005101.1; NM_005110.3.
DR   UniGene; Hs.696497; -.
DR   ProteinModelPortal; O94808; -.
DR   BioGrid; 115270; 30.
DR   IntAct; O94808; 2.
DR   STRING; 9606.ENSP00000253778; -.
DR   DrugBank; DB00130; L-Glutamine.
DR   MEROPS; C44.972; -.
DR   iPTMnet; O94808; -.
DR   PhosphoSitePlus; O94808; -.
DR   BioMuta; GFPT2; -.
DR   EPD; O94808; -.
DR   MaxQB; O94808; -.
DR   PaxDb; O94808; -.
DR   PeptideAtlas; O94808; -.
DR   PRIDE; O94808; -.
DR   DNASU; 9945; -.
DR   Ensembl; ENST00000253778; ENSP00000253778; ENSG00000131459.
DR   GeneID; 9945; -.
DR   KEGG; hsa:9945; -.
DR   UCSC; uc003mlw.2; human.
DR   CTD; 9945; -.
DR   DisGeNET; 9945; -.
DR   GeneCards; GFPT2; -.
DR   HGNC; HGNC:4242; GFPT2.
DR   HPA; HPA056892; -.
DR   HPA; HPA059910; -.
DR   MIM; 603865; gene.
DR   neXtProt; NX_O94808; -.
DR   OpenTargets; ENSG00000131459; -.
DR   PharmGKB; PA28652; -.
DR   eggNOG; KOG1268; Eukaryota.
DR   eggNOG; COG0449; LUCA.
DR   GeneTree; ENSGT00390000010049; -.
DR   HOGENOM; HOG000258898; -.
DR   HOVERGEN; HBG051724; -.
DR   InParanoid; O94808; -.
DR   KO; K00820; -.
DR   OMA; CLHAVGN; -.
DR   OrthoDB; EOG091G02N5; -.
DR   PhylomeDB; O94808; -.
DR   TreeFam; TF300864; -.
DR   Reactome; R-HSA-446210; Synthesis of UDP-N-acetyl-glucosamine.
DR   UniPathway; UPA00113; UER00528.
DR   ChiTaRS; GFPT2; human.
DR   GenomeRNAi; 9945; -.
DR   PRO; PR:O94808; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000131459; -.
DR   CleanEx; HS_GFPT2; -.
DR   ExpressionAtlas; O94808; baseline and differential.
DR   Genevisible; O94808; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0097367; F:carbohydrate derivative binding; IEA:InterPro.
DR   GO; GO:0004360; F:glutamine-fructose-6-phosphate transaminase (isomerizing) activity; TAS:Reactome.
DR   GO; GO:0006112; P:energy reserve metabolic process; TAS:ProtInc.
DR   GO; GO:0006002; P:fructose 6-phosphate metabolic process; TAS:ProtInc.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; TAS:Reactome.
DR   Gene3D; 3.60.20.10; -; 1.
DR   InterPro; IPR017932; GATase_2_dom.
DR   InterPro; IPR005855; GlmS_trans.
DR   InterPro; IPR029055; Ntn_hydrolases_N.
DR   InterPro; IPR001347; SIS.
DR   Pfam; PF01380; SIS; 2.
DR   SUPFAM; SSF56235; SSF56235; 2.
DR   TIGRFAMs; TIGR01135; glmS; 1.
DR   PROSITE; PS51278; GATASE_TYPE_2; 1.
DR   PROSITE; PS51464; SIS; 2.
PE   1: Evidence at protein level;
KW   Aminotransferase; Complete proteome; Glutamine amidotransferase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000250}.
FT   CHAIN         2    682       Glutamine--fructose-6-phosphate
FT                                aminotransferase [isomerizing] 2.
FT                                /FTId=PRO_0000135283.
FT   DOMAIN        2    288       Glutamine amidotransferase type-2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00609}.
FT   DOMAIN      360    499       SIS 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00797}.
FT   DOMAIN      531    672       SIS 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00797}.
FT   REGION      377    378       Substrate-binding.
FT                                {ECO:0000250|UniProtKB:Q06210}.
FT   REGION      422    424       Substrate-binding.
FT                                {ECO:0000250|UniProtKB:Q06210}.
FT   ACT_SITE      2      2       For GATase activity.
FT                                {ECO:0000250|UniProtKB:P14742}.
FT   BINDING     427    427       Substrate.
FT                                {ECO:0000250|UniProtKB:Q06210}.
FT   BINDING     578    578       Substrate.
FT                                {ECO:0000250|UniProtKB:Q06210}.
FT   MOD_RES     100    100       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q06210}.
FT   MOD_RES     244    244       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT     471    471       I -> V (in dbSNP:rs2303007).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_013311.
SQ   SEQUENCE   682 AA;  76931 MW;  A090D75526F3192B CRC64;
     MCGIFAYMNY RVPRTRKEIF ETLIKGLQRL EYRGYDSAGV AIDGNNHEVK ERHIQLVKKR
     GKVKALDEEL YKQDSMDLKV EFETHFGIAH TRWATHGVPS AVNSHPQRSD KGNEFVVIHN
     GIITNYKDLR KFLESKGYEF ESETDTETIA KLIKYVFDNR ETEDITFSTL VERVIQQLEG
     AFALVFKSVH YPGEAVATRR GSPLLIGVRS KYKLSTEQIP ILYRTCTLEN VKNICKTRMK
     RLDSSACLHA VGDKAVEFFF ASDASAIIEH TNRVIFLEDD DIAAVADGKL SIHRVKRSAS
     DDPSRAIQTL QMELQQIMKG NFSAFMQKEI FEQPESVFNT MRGRVNFETN TVLLGGLKDH
     LKEIRRCRRL IVIGCGTSYH AAVATRQVLE ELTELPVMVE LASDFLDRNT PVFRDDVCFF
     ISQSGETADT LLALRYCKDR GALTVGVTNT VGSSISRETD CGVHINAGPE IGVASTKAYT
     SQFISLVMFG LMMSEDRISL QNRRQEIIRG LRSLPELIKE VLSLEEKIHD LALELYTQRS
     LLVMGRGYNY ATCLEGALKI KEITYMHSEG ILAGELKHGP LALIDKQMPV IMVIMKDPCF
     AKCQNALQQV TARQGRPIIL CSKDDTESSK FAYKTIELPH TVDCLQGILS VIPLQLLSFH
     LAVLRGYDVD FPRNLAKSVT VE
//
